BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20406989)

  • 21. 4-1BB ligand signaling to T cells limits T cell activation.
    Eun SY; Lee SW; Xu Y; Croft M
    J Immunol; 2015 Jan; 194(1):134-41. PubMed ID: 25404362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
    Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
    Kuang Y; Weng X; Liu X; Zhu H; Chen Z; Jiang B; Chen H
    Cancer Lett; 2010 Jul; 293(2):254-62. PubMed ID: 20149524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression.
    Ragonnaud E; Andersson AM; Pedersen AE; Laursen H; Holst PJ
    Vaccine; 2016 Apr; 34(18):2147-56. PubMed ID: 27004934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel agonist of 4-1BB costimulatory receptor shows therapeutic efficacy against a tobacco carcinogen-induced lung cancer.
    Gulen AE; Rudraboina R; Tarique M; Ulker V; Shirwan H; Yolcu ES
    Cancer Immunol Immunother; 2023 Nov; 72(11):3567-3579. PubMed ID: 37605009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term antigen-specific immune response by an oncolytic adenovirus encoding SP-SA-E7-4-1BBL in HPV-16 cancer model.
    Martinez-Perez AG; Garza-Morales R; Loera-Arias MJ; Villa-Cedillo SA; Garcia-Garcia A; Rodriguez-Rocha H; Flores-Maldonado OE; Valdes J; Perez-Trujillo JJ; Saucedo-Cardenas O
    Mol Biol Rep; 2024 Mar; 51(1):408. PubMed ID: 38460043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity.
    Ahn YH; Hong SO; Kim JH; Noh KH; Song KH; Lee YH; Jeon JH; Kim DW; Seo JH; Kim TW
    Clin Exp Immunol; 2015 Jul; 181(1):164-78. PubMed ID: 25753156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.
    Xiong G; Husseiny MI; Song L; Erdreich-Epstein A; Shackleford GM; Seeger RC; Jäckel D; Hensel M; Metelitsa LS
    Int J Cancer; 2010 Jun; 126(11):2622-34. PubMed ID: 19824039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
    Zhou H; Luo Y; Kaplan CD; Krüger JA; Lee SH; Xiang R; Reisfeld RA
    Blood; 2006 Apr; 107(8):3251-7. PubMed ID: 16368879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes Simplex Virus Glycoprotein D Targets a Specific Dendritic Cell Subset and Improves the Performance of Vaccines to Human Papillomavirus-Associated Tumors.
    Porchia BFMM; Moreno ACR; Ramos RN; Diniz MO; de Andrade LHTM; Rosa DS; Barbuto JAM; Boscardin SB; Ferreira LCS
    Mol Cancer Ther; 2017 Sep; 16(9):1922-1933. PubMed ID: 28522585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
    Macdonald DC; Hotblack A; Akbar S; Britton G; Collins MK; Rosenberg WC
    J Immunol; 2014 Nov; 193(10):5056-64. PubMed ID: 25305314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation.
    Lee SJ; Song L; Yang MC; Mao CP; Yang B; Yang A; Jeang J; Peng S; Wu TC; Hung CF
    Vaccine; 2015 Mar; 33(13):1549-55. PubMed ID: 25701675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.
    Dinc G; Pennington JM; Yolcu ES; Lawrenz MB; Shirwan H
    Vaccine; 2014 Sep; 32(39):5035-40. PubMed ID: 25045812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.
    Tan JT; Whitmire JK; Ahmed R; Pearson TC; Larsen CP
    J Immunol; 1999 Nov; 163(9):4859-68. PubMed ID: 10528187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin.
    Mansilla C; Berraondo P; Durantez M; Martínez M; Casares N; Arribillaga L; Rudilla F; Fioravanti J; Lozano T; Villanueva L; Sarobe P; Borrás F; Leclerc C; Prieto J; Lasarte JJ
    Int J Cancer; 2012 Aug; 131(3):641-51. PubMed ID: 21898393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY; Park SH; Nam HJ; Choi DH; Sung YC
    J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.
    Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H
    J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model.
    Alson D; Schuyler SC; Yan BX; Samimuthu K; Qiu JT
    Front Immunol; 2020; 11():927. PubMed ID: 32547541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: In vivo effects of vaccine containing 4-1BBL and CEACAM6.
    Jin C; Liu Y; Zhu J; Xia T; Zhang B; Fei Y; Ma B; Ye J; Chen W
    Oncol Rep; 2015 Jun; 33(6):2837-44. PubMed ID: 25872647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.